SUBSCRIBE
SUBSCRIBE
News   Policy

Pfizer Inc. Pulls Leukemia Drug Mylotarg From U.S. Market After Deaths, No Proven Benefit

March 31, 2010 | 
1 min read

(Reuters) - Drugmaker Pfizer Inc is pulling a decade-old leukemia medicine off the U.S. market after a study found a higher death rate and no benefit for patients.

Legal
Pfizer
MORE ON THIS TOPIC
The EMA's former headquarters in London
Europe
Biogen, Eisai Continue Leqembi’s European Rally as CHMP Reaffirms Positive Opinion
March 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Editorial
Transparency Missing in Action at HHS Despite Leaders’ Calls for Clarity
February 28, 2025
 · 
4 min read
 · 
Heather McKenzie
Pictured: A syringe broken in half with long hallway in background/Nicole Bean for BioSpace
Vaccines
Meeting of FDA’s Vaccines Advisory Panel Canceled as Kennedy Settles Into HHS
February 27, 2025
 · 
2 min read
 · 
Tristan Manalac
External view of the U.S. Capitol building
Government
Congress Re-Introduces EPIC Act to Remove IRA’s ‘Pill Penalty’
February 26, 2025
 · 
2 min read
 · 
Tristan Manalac